Drugs & TargetsFree FDA grants QIDP and Fast Track Designations to Cidara September 28, 2018Vol.44 No.36
Drugs & TargetsFree Blincyto approved In Japan for relapsed or refractory B-cell ALL September 28, 2018Vol.44 No.36
Clinical RoundupFree CT screening reduces lung cancer mortality, NELSON study finds September 28, 2018Vol.44 No.36
Clinical RoundupFree Imfinzi significantly improves OS in unresectable, stage III NSCLC September 28, 2018Vol.44 No.36
Clinical RoundupFree Tecentriq + chemo significantly improves OS as initial treatment for ES-SCLC September 28, 2018Vol.44 No.36
Clinical RoundupFree Atezolizumab + carboplatin & pemetrexed improves PFS in stage IV non-squamous NSCLC September 28, 2018Vol.44 No.36
Clinical RoundupFree Myriad’s Variant Reclassification Study published in JAMA September 28, 2018Vol.44 No.36
Clinical RoundupFree Alunbrig improves PFS by over 50% vs. crizotinib in first-line advanced ALK+ NSCLC September 28, 2018Vol.44 No.36
Clinical RoundupFree Cancer patients have lower risk of opioid-related death than general public September 28, 2018Vol.44 No.36
